.jpg)
Top firms will have enough firepower to go for foreign M&As, given their balance sheet growth, say bankers.
The regulator will conduct forensic audit of all the seized documents, laptops, and mobile phones, which are suspected to be involved in the fraudulent activity, reports Shrimi Choudhary.
Leading IT companies i-flex Software and Satyam Computers have made their way to Forbes Global's list of 100 'best under a billion' companies in Asia Pacific.
Indian companies may be able to make generic copies of Roche's anti-influenza drug Tamiflu with its patent still pending in the country.
According to industry estimates, the sector's revenue would increase eight-10 per cent in 2013-14, against 12 per cent in 2012-13.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
00 hours. The overall investors' wealth, measured in terms of valuation of all listed stocks, was down by nearly Rs 6 lakh crore in early morning trade, from nearly Rs 111.44 lakh crore at the end of Tuesday's trade.
At $2.6 trillion, the Indian economy is currently ranked sixth in the world behind the US, China, Japan, Germany and the UK.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The market proved tenacious in afternoon trades on buying interest in Old Economy and FMCG stocks. In addition, renewed buying was observed in banking stocks.
In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
The 50-issue NSE Nifty in range-bound movements settled higher by 59.15 points, or 0.58 per cent, at 10,252.10.
The Nifty finished the day at 10,265.65, a hefty gain of 98.95 points, or 0.97 per cent, after shuttling between 10,270.85 and 10,195.25.
The benchmark Sensex gained 4,642.84 points, or 16.%, while the broader NSE Nifty surged 1,572.85 points, or 18.20% during this period.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries
Secretary of State for Foreign Affairs William Hague and Chancellor of the Exchequer George Osbourne, heading the largest business and ministerial delegation ever, arrived in Mumbai, their first port of call, during a two-day visit to the country.
Revival in domestic business should also help overall revenue growth.
The Sensex closed with a gain of 16 points at 3,780.\n\n\n\n
In New York, the dollar fell against the British pound on Wednesday after the Bank of England raised its projections for UK growth in 2014. However, analysts warned that gains against the dollar could be limited.
'The majority of the spread is by people coughing, or sneezing or talking loudly, in a very short distance, two metres from one another, and a mask will prevent that sort of transmission.'
Adani Ports, BHEL, Tata Motors, ONGC, Mahindra & Mahindra and Tata Steel were the top losers.
Investor wealth on Thursday soared by Rs 1 lakh crore, triggered by heavy buying in the stock market, with the BSE benchmark Sensex surging about 382 points to close at near six-week high levels.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' stock market queries. Ajit will offer his unbiased views on a weekly basis
IT, pharma and FMCG stocks are the top performers in 2013.
The B-school also witnessed new roles in the domain.
The S&P BSE Sensex dropped 207 points to end at 25,230.
S&P BSE Midcap and the S&P BSE Smallcap indices gained 2% and 1.6% respectively
Costlier oil due to rising conflict in Iraq threatens to hurt the India economy that is already battling price rise and slowing growth.
Drugs under exemption make up roughly 95 per cent of the antiretrovirals used by India's AIDS patients
A recent report has suggested that future patent expires in the cardiac and anti-diabetes space would form a good opportunity for smaller firms, given their franchise in these segments.
India serves as the company's R&D hub as it morphs into a health tech major.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances